Vitaspring Biomedical VSBC Income Statement (2017-2026)

OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT
Reported Financials

Vitaspring Biomedical Quarterly Income Statement

Periods 39 quarters
Latest Jul 2026

Vitaspring Biomedical reported net income of -$0.16M for the quarter ended Jul 2026. This income statement covers 39 quarters of results from Jan 2017 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Revenue & cost
Revenue
0.20M3.49M1.49M-1.49M
Cost of RevenueCost of Rev
0.18M2.02M0.92M2.41M
Gross Profit
0.02M1.47M0.57M-3.90M
Operating items
Selling, General & AdministrativeSG&A
0.16M0.63M0.22M0.17M0.18M0.26M0.30M0.35M0.23M0.23M0.22M0.22M0.12M0.13M0.07M0.01M0.14M0.08M0.08M0.01M
Other Operating ExpensesOther Opex
0.01M50.00-637.00124.00-0.25M-0.27M0.05M-0.15M-0.12M-0.09M-0.04M0.04M-0.12M-0.05M-0.06M0.10M
Operating ExpensesOpex
0.16M0.63M0.07M0.05M-0.00M0.05M0.09M0.07M0.27M0.07M1.000.03M0.03M0.10M0.02M0.04M0.01M0.16M
Operating IncomeOp. Inc
0.14M1.42M0.34M-0.17M-0.18M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.12M-0.13M-0.07M-0.10M-0.14M-0.08M-0.08M-0.16M
EBIT
0.14M1.42M0.34M-0.17M-0.18M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.12M-0.13M-0.07M-0.10M-0.14M-0.08M-0.08M-0.16M
Non-operating items
Other Non Operating IncomeOther Non Op Inc.
0.01M-637.00124.000.01M
Net income details
EBT
0.14M1.42M0.35M-0.17M-0.18M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.12M-0.13M-0.07M-0.10M-0.14M-0.08M-0.08M-0.16M
Tax ProvisionsTaxes
0.03M0.19M0.07M-0.03M-0.05M-0.00M0.08M0.02M0.01M0.01M0.01M
Profit After TaxPAT
0.11M1.23M0.28M-0.14M-0.14M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.20M-0.14M-0.08M-0.11M-0.14M-0.08M-0.08M-0.16M
Equity Income
Income from Continuing OperationsIncome (Continuing)
-0.14M1.23M0.28M-0.14M-0.14M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.20M-0.14M-0.08M-0.11M-0.14M-0.08M-0.08M-0.16M
Consolidated Net IncomeConsol Net Inc.
-0.14M1.23M0.28M-0.14M-0.14M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.20M-0.14M-0.08M-0.11M-0.14M-0.08M-0.08M-0.16M
Income towards Parent CompanyParent Net Inc
-0.14M1.23M0.28M-0.14M-0.14M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.20M-0.14M-0.08M-0.11M-0.14M-0.08M-0.08M-0.16M
Net Income towards Common StockholdersNet Income
-0.14M1.23M0.28M-0.14M-0.14M-4.16M-0.30M-0.35M-0.23M-0.23M-0.22M-0.22M-0.20M-0.14M-0.08M-0.11M-0.14M-0.08M-0.08M-0.16M
Additional items
EPS (Basic)
0.000.010.000.000.00-0.020.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS (Diluted)
0.000.010.000.000.00-0.020.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Shares Outstanding
206.52M205.98M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M206.52M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
205.42M205.98M206.52M206.52M206.52M206.52M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
206.52M206.52M206.52M206.52M206.52M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M207.03M
EBITDA
0.14M1.42M0.35M-0.17M-0.18M-4.16M-0.30M-0.35M-0.23M-0.22M-0.21M-0.22M-0.12M-0.12M-0.07M-0.10M-0.13M-0.08M-0.07M
Tax Rate
18.44%13.20%21.33%

Vitaspring Biomedical Income Statement API

Pull Vitaspring Biomedical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VSBC&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY